Advertisement

Topics

ISTA Pharmaceuticals Company Profile

02:54 EDT 19th June 2018 | BioPortfolio

ISTA Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products for serious conditions of the eye. ISTA has three approved products, Xibrom™ (for the treatment of ocular inflammation following cataract surgery), Istalol® (for the treatment of glaucoma) and Vitrase® (for use as a "spreading agent"). We launched Istalol® during Q3 2004, Vitrase® during Q1 2005 and Xibrom™ during Q2 2005. We have received an approvable letter for Vitrase® (for the treatment of vitreous hemorrhage). We have other prescription products under development, including a tobramycin prednisolone acetate for the treatment of inflammation where a bacterial infection might be present, ecabet sodium, for the treatment of dry eye, and Caprogel® for the treatment of hyphema. In order to further build our pipeline as a specialty pharmaceutical company, we expect to acquire complementary products in ophthalmology, either already marketed or in late-stage development. ISTA has been well financed, and our management team has extensive experience in the development and commercialization of ophthalmic pharmaceuticals.

Location

15295 Alton Parkway
Irvine
California
92618
United States of America

Contact

Phone: (949) 788-6000
Fax: (949) 788-6010


News Articles [472 Associated News Articles listed on BioPortfolio]

Ophthotech Announces Election of Jane Pritchett Henderson, Chief Financial Officer and Senior Vice President of Corporate Development at Voyager Therapeutics, to Its Board of Directors

Ophthotech Corporation (NASDAQ: OPHT) announced today the election of Jane Pritchett Henderson, Chief Financial Officer and Senior Vice President of Corporate Development at Voyag...

Critical Contrast: Ironwood Pharmaceuticals

Ironwood Pharmaceuticals and Infinity Pharmaceuticals are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, risk, d...

Critical Analysis: Sagent Pharmaceuticals

Sagent Pharmaceuticals and Lannett are both pharmaceuticals - nec companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analy...

GW Pharmaceuticals ADR: Kommt es jetzt zum Ausbruch? Trading-Chance!

Es gibt ein weiteres Unternehmen GW Pharmaceuticals, das vorwiegend Cannabis herstellt und somit als "Pflanzenzüchter" zu werten ist. GW Pharmaceuticals ADR ist ein Biotech-Unternehmen, das sich zw.....

Telix Pharmaceuticals Limited: Telix Pharmaceuticals, INSERM and ARRONAX Enter into Translational Research Partnership

MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) ("Telix", the "Company"), a clinical-stage biopharmaceutical company focused on ...

Newly Merged Amneal Pharmaceuticals to Push into the Biosimilar Space

Earlier this week Amneal Pharmaceuticals and Impax Laboratories completed their business merger, forming the new Amneal Pharmaceuticals. The combined companies are now the fifth largest generics busin...

Emerald Health Pharmaceuticals Inc.: Emerald Health Pharmaceuticals to Present at Cannabis Invest UK Conference

SAN DIEGO, CA / ACCESSWIRE / April 19, 2018 / Emerald Health Pharmaceuticals Inc. (EHP), which is developing medicines based on cannabinoid science, announced today that Dr. Jim DeMesa, CEO, will p...

Cantex Pharmaceuticals, Inc. Announces FDA Orphan Drug Designation Has Been Granted to CX-01 for Treatment of Acute Myeloid Leukemia

WESTON, Fla., January 3, 2018 -- Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals that improve the treatment of cancers and other life-t...

Drugs and Medications [277 Associated Drugs and Medications listed on BioPortfolio]

Bepreve [Ista Pharmaceuticals, Inc]

These highlights do not include all the information needed to use BEPREVE (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE.BEPREVE (...

Bepreve [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use BEPREVE™ (bepotastine besilate ophthalmic solution) 1.5% safely and effectively. See full prescribing information for BEPREVE™.BEP...

Bromday [Ista Pharmaceuticals, Inc]

These highlights do not include all the information needed to use Bromday™ (bromfenac ophthalmic solution) 0.09% safely and effectively. See full prescribing information for Bromday. Bromday  (brom...

Xibrom [Ista Pharmaceuticals, Inc]

XIBROM™ (bromfenac ophthalmic solution) 0.09%

Bromday [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use Bromday™ (bromfenac ophthalmic solution) 0.09% safely and effectively. See full prescribing information for Bromday. Bromday  (brom...

PubMed Articles [136 Associated PubMed Articles listed on BioPortfolio]

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Genetics of familial hypercholesterolemia: a tool for development of novel lipid lowering pharmaceuticals?

Familial hypercholesterolemia is characterized by high LDL cholesterol and an elevated risk to develop coronary heart disease. Mutations in LDL receptor-mediated cholesterol uptake are the main cause ...

Post-production handling and administration of protein pharmaceuticals and potential instability issues.

The safety and efficacy of protein pharmaceuticals depend not only on biological activity, but also on purity levels. Impurities may be process related due to limitations in manufacturing, or product ...

A General Strategy for Site-Selective Incorporation of Deuterium and Tritium into Pyridines, Diazines and Pharmaceuticals.

Methods to incorporate deuterium and tritium atoms into organic molecules are valuable for medicinal chemistry. The prevalence of pyridines and diazines in pharmaceuticals means that new ways to label...

Environmental concentrations of pharmaceuticals directly affect phytoplankton and effects propagate through trophic interactions.

Pharmaceuticals are found in freshwater ecosystems where even low concentrations in the range of ng Lmay affect aquatic organisms. In the current study, we investigated the effects of chronic exposure...

Clinical Trials [216 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1324 Associated Companies listed on BioPortfolio]

ISTA Pharmaceuticals

ISTA Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of unique and uniquely improved ophthalmic products for serious conditions of the eye. ISTA...

ISTA Pharmaceuticals, Inc.

Cascade TEK

Since 1992, Cascade TEK has provided drying solutions for military, aerospace, medical and automotive industries. Our forced air laboratory and vacuum ovens are made in the USA. C...

Maelor Pharmaceuticals Ltd.

Maelor is a publicly listed (AIM:MLR) specialist critical care pharmaceuticals and devices company. The Company has developed an expertise in bringing both pharmaceuticals and devices to the market as...

Vericool, Inc.

Based in Livermore, Calif., Vericool delivers sustainable packaging that protects products, people and the planet. Recyclapostable™ Vericoolers® are the only high performi...

More Information about "ISTA Pharmaceuticals" on BioPortfolio

We have published hundreds of ISTA Pharmaceuticals news stories on BioPortfolio along with dozens of ISTA Pharmaceuticals Clinical Trials and PubMed Articles about ISTA Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ISTA Pharmaceuticals Companies in our database. You can also find out about relevant ISTA Pharmaceuticals Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record